Health Services Research: A Critical Need in Stroke Care

Brystana G. Kaufman; Anna Kucharska-Newton; Janet Prvu Bettger

doi:10.1161/STROKEAHA.118.024093

Health Services Research: A Critical Need in Stroke Care

Brystana G. Kaufman, Anna Kucharska-Newton, Janet Prvu Bettger

Epidemiology

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Evidence defining high-quality stroke care has improved dramatically in the past 20 years; however, the gap between evidence and practice persists in stroke prevention, treatment, and rehabilitation.1 Although clinical trials have been instrumental in advancing the science supporting evidence- based guidelines, research is needed to identify gaps and factors contributing to gaps in care and outcomes and to develop strategies that promote uptake of evidence-based treatment and services for stroke patients. This article discusses health services research (HSR) as a multidisciplinary field encompassing outcomes research, implementation science, and financial evaluations that can address critical evidence, practice and policy gaps in stroke care.

Original language	English
Pages (from-to)	E121-E124
Journal	Stroke
Volume	50
Issue number	5
DOIs	https://doi.org/10.1161/STROKEAHA.118.024093
State	Published - May 1 2019

Bibliographical note

Funding Information:
Opportunities to compare long term costs of care and effectiveness of preventive and therapeutic therapies are abundant. Comparative clinical and cost-effectiveness research of different therapeutic modalities helps payers, providers, and patients in decision-making. Cost-effectiveness models simulate real-world population outcomes and estimate the incremental cost relative to the net gain in quality-adjusted life years. For example, data from the Interventional Management of Stroke III Trial, funded by the United States National Institutes of Health, were used to evaluate variations in outcomes and cost observed over 12 months for subjects receiving endovascular therapy compared with intravenous tissue-type plasminogen activator alone. Financial evaluations can demonstrate the economic incentive for investment in improvements in the care process for acute and postacute stroke.

Funding Information:
National Institutes of Health (eg, T32 National Research Service Award)

Funding Information:
J. Prvu Bettger receives Research funding from the Patient-Centered Outcomes Research Institute, National Institutes of Health, and the Medical Research Council. The other authors report no conflicts.

Publisher Copyright:
© 2019 American Heart Association, Inc.

Keywords

caregivers
health behavior
health services research
patients
population health

ASJC Scopus subject areas

Clinical Neurology
Cardiology and Cardiovascular Medicine
Advanced and Specialized Nursing

Access to Document

10.1161/STROKEAHA.118.024093

Cite this

@article{cec597bccd48451da36703f1abed9597,

title = "Health Services Research: A Critical Need in Stroke Care",

abstract = "Evidence defining high-quality stroke care has improved dramatically in the past 20 years; however, the gap between evidence and practice persists in stroke prevention, treatment, and rehabilitation.1 Although clinical trials have been instrumental in advancing the science supporting evidence- based guidelines, research is needed to identify gaps and factors contributing to gaps in care and outcomes and to develop strategies that promote uptake of evidence-based treatment and services for stroke patients. This article discusses health services research (HSR) as a multidisciplinary field encompassing outcomes research, implementation science, and financial evaluations that can address critical evidence, practice and policy gaps in stroke care.",

keywords = "caregivers, health behavior, health services research, patients, population health",

author = "Kaufman, {Brystana G.} and Anna Kucharska-Newton and {Prvu Bettger}, Janet",

note = "Funding Information: Opportunities to compare long term costs of care and effectiveness of preventive and therapeutic therapies are abundant. Comparative clinical and cost-effectiveness research of different therapeutic modalities helps payers, providers, and patients in decision-making. Cost-effectiveness models simulate real-world population outcomes and estimate the incremental cost relative to the net gain in quality-adjusted life years. For example, data from the Interventional Management of Stroke III Trial, funded by the United States National Institutes of Health, were used to evaluate variations in outcomes and cost observed over 12 months for subjects receiving endovascular therapy compared with intravenous tissue-type plasminogen activator alone. Financial evaluations can demonstrate the economic incentive for investment in improvements in the care process for acute and postacute stroke. Funding Information: National Institutes of Health (eg, T32 National Research Service Award) Funding Information: J. Prvu Bettger receives Research funding from the Patient-Centered Outcomes Research Institute, National Institutes of Health, and the Medical Research Council. The other authors report no conflicts. Publisher Copyright: {\textcopyright} 2019 American Heart Association, Inc.",

year = "2019",

month = may,

day = "1",

doi = "10.1161/STROKEAHA.118.024093",

language = "English",

volume = "50",

pages = "E121--E124",

number = "5",

}

TY - JOUR

T1 - Health Services Research

T2 - A Critical Need in Stroke Care

AU - Kaufman, Brystana G.

AU - Kucharska-Newton, Anna

AU - Prvu Bettger, Janet

N1 - Funding Information: Opportunities to compare long term costs of care and effectiveness of preventive and therapeutic therapies are abundant. Comparative clinical and cost-effectiveness research of different therapeutic modalities helps payers, providers, and patients in decision-making. Cost-effectiveness models simulate real-world population outcomes and estimate the incremental cost relative to the net gain in quality-adjusted life years. For example, data from the Interventional Management of Stroke III Trial, funded by the United States National Institutes of Health, were used to evaluate variations in outcomes and cost observed over 12 months for subjects receiving endovascular therapy compared with intravenous tissue-type plasminogen activator alone. Financial evaluations can demonstrate the economic incentive for investment in improvements in the care process for acute and postacute stroke. Funding Information: National Institutes of Health (eg, T32 National Research Service Award) Funding Information: J. Prvu Bettger receives Research funding from the Patient-Centered Outcomes Research Institute, National Institutes of Health, and the Medical Research Council. The other authors report no conflicts. Publisher Copyright: © 2019 American Heart Association, Inc.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Evidence defining high-quality stroke care has improved dramatically in the past 20 years; however, the gap between evidence and practice persists in stroke prevention, treatment, and rehabilitation.1 Although clinical trials have been instrumental in advancing the science supporting evidence- based guidelines, research is needed to identify gaps and factors contributing to gaps in care and outcomes and to develop strategies that promote uptake of evidence-based treatment and services for stroke patients. This article discusses health services research (HSR) as a multidisciplinary field encompassing outcomes research, implementation science, and financial evaluations that can address critical evidence, practice and policy gaps in stroke care.

AB - Evidence defining high-quality stroke care has improved dramatically in the past 20 years; however, the gap between evidence and practice persists in stroke prevention, treatment, and rehabilitation.1 Although clinical trials have been instrumental in advancing the science supporting evidence- based guidelines, research is needed to identify gaps and factors contributing to gaps in care and outcomes and to develop strategies that promote uptake of evidence-based treatment and services for stroke patients. This article discusses health services research (HSR) as a multidisciplinary field encompassing outcomes research, implementation science, and financial evaluations that can address critical evidence, practice and policy gaps in stroke care.

KW - caregivers

KW - health behavior

KW - health services research

KW - patients

KW - population health

UR - http://www.scopus.com/inward/record.url?scp=85065112935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065112935&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.118.024093

DO - 10.1161/STROKEAHA.118.024093

M3 - Article

C2 - 30890107

AN - SCOPUS:85065112935

SN - 0039-2499

VL - 50

SP - E121-E124

JO - Stroke

JF - Stroke

IS - 5

ER -

Health Services Research: A Critical Need in Stroke Care

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this